THE PREVALENCE AND SOME RELATED FACTORS TO FATTY LIVER OF STAFF OF HEALTH PROTECTION BOARD IN SOC TRANG PROVINCIAL PARTY COMMITTEE, 2020-2021

Cao Tri Pham 1,, Ngoc Dung Tran 2
1 Soc Trang General Hospital
2 Can Tho University of Medicine and Pharmacy

Main Article Content

Abstract

Can Tho University of Medicine and Pharmacy


Background: Fatty liver is a common liver disease in the world, especially in developed countries, and is a risk factor for other chronic diseases. Objectives: To determine the rate of fatty liver and find out some related factors to fatty liver in the staff of the Health Protection Board of Soc Trang Provincial Party Committee in 2020-2021. Materials and methods: A cross-sectional descriptive study was conducted on 990 officials from the Health Protection Committee of the Soc Trang Provincial Party Committee, who were managed to have periodic health checks at the Examination Department, Soc Trang General Hospital from May 2020 to February 2021. Diagnose of fatty liver by abdominal ultrasound, according to Hagen-Ansert criteria. Data processing using SPSS 20.0. Results: The fatty liver rate accounted for 15.8% (156/990 people). In which, grade I accounted for 40.4%; grade II accounted for 41.0% and grade III for 18.6%. There were 5 factors related to fatty liver like gender, education, overweight and obesity, abdominal obesity, metabolic syndrome with p<0.001. Conclusion: The rate of fatty liver in the staff of the Health Protection Committee is quite high (15.8%), it is need to strengthen the regular inspection of fatty liver for them, in order to have early intervention. 

Article Details

References

1. Bệnh viện Đa khoa tỉnh Sóc Trăng (2019), Báo cáo công tác khám chữa bệnh tại bệnh viện Đa khoa tỉnh Sóc Trăng năm 2019, Kế hoạch năm 2020.
2. Lê Đệ (2016), Nghiên cứu tình hình, mức độ, đặc điểm cận lâm sàng và một số yếu tố liên quan ở bệnh nhân gan nhiễm mỡ tại bệnh viện trường đại học y dược Cần Thơ, Luận văn tốt nghiệm bác sỹ đa khoa trường đại học y dược Cần Thơ
3. Phạm Hồng Phương (2018), Nghiên cứu đặc điểm lâm sàng, cận lâm sàng và tổn thương động mạch vành ở bệnh nhân gan nhiễm mỡ không do rượu, Luận án tiến sỹ Y học, Viện nghiên cứu khoa học Y dược lâm sàng 108.
4. Huỳnh Kim Phượng (2017), “Tương quan giữa gan nhiễm mỡ với hội chứng chuyển hóa và tăng acid uric máu”, Y học thành phố Hồ Chí Minh, Tập 21 (5), tr. 211-218.
5. Amarapurkar, Deepak N., Hashimoto, E., Lesmana, Laurentius A. et al. (2007), "How common is non-alcoholic fatty liver disease in the Asia– Pacific region and are there local differences?", Journal of Gastroenterology and Hepatology. 22(6), pp. 788-93.
6. Chalasani, N., Younossi, Z., Lavine, J.E. et al. (2012), "The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological
Association, American Association for the Study of Liver Diseases, and American College
of Gastroenterology", Gastroenterology. 142(7), pp. 1592-609
7. Chitturi, S., Farrell, Geoffrey C., Hashimoto, E. et al. (2007), "Nonalcoholic fatty liver disease in the Asia–Pacific region: Definitions and overview of proposed guidelines", Journal of Gastroenterology and Hepatology. 22(6), pp. 778-87.
8. Lewis JR., Mohanty SR. (2010), "Nonalcoholic Fatty Liver Disease: A Review and Update", Digestive Diseases and Sciences. 55(3), pp. 560-78.
9. Sun, L. and Lu, S. Z. (2011), "Association between non-alcoholic fatty liver disease and coronary artery disease severity", Chin Med J (Engl). 124(6), pp. 867-72.
10. Wong, Vincent W-S., Wong, Grace L-H., Yip, Gabriel W-K. et al. (2011), "Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease", Gut. 60(12), pp. 1721-27.
11. Zhu, J. Z., Hansen, K.H., Wan, X.Y. et al. (2016), "Clinical guidelines of non-alcoholic fatty liver disease: A systematic review", World J Gastroenterol. 22(36), pp. 8226-33.
12. Sur G (2015), “Is the non-Alcolic fatty liver disease part of metabolic syndrome?”, diabetes & Metabolism, Vol 6 (4), 1000526.
13. Yang KC (2016), “Association of non-alcoholic fatty liver disease with metabilic syndrome independently of central obesity and insulin resistance”, Scientific reports, 627034.